Search Results for: reserpine

update Dec 2014: TIME TO MANDATE LOWDOSE RESERPINE+ LOWDOSE AMILOZIDE+- AMLODIPINE(/ DIHYDRALAZINE) AS FIRST LINE THERAPY OF AVERAGE HYPERTENSION.

TIME TO COMPELL FIRST LINE POLYTHERAPY OF COMMON  HYPERTENSION WITH LOWDOSE RESERPINE+ LOWDOSE AMILOZIDE; with AMLODIPINE as 4th add-on if needed. dedicated;  for inspiration and help,  to: Drs YK Seedat; Roy Keeton;  Norman Kaplan; Colin Dollery, Harry Seftel; Josh Barzilay; … Continue reading

LOWDOSE RESERPINE-AMILOZIDE IS THE ONLY PRIMARY DRUG THERAPY OF UNCOMPLICATED HYPERTENSION TO AVOID COMPLICATIONS AND BEST REDUCE MORBIDITY AND MORTALITY

ABSTRACT: When modern antihypertensive drugs cost far more than the old and tried, and have around 40% risk of adverse effects (Girerd 2002 Paris), and give inferior risk reduction, it is unethical for routine hypertension patients initially to  be  prescribed … Continue reading

RESERPINE: WHY ARE IT’S BENEFITS FOR HYPERTENSION BEING IGNORED?

It is now a lifetime ago  since the detailed trial report  showing  the major blood-pressure-lowering  benefit of reserpine on it’s own (without any diet/ salt restriction) in moderate hypertension  by Lieutenant-Colonel Inder Singh in the BMJ in 1955 (fulltext on … Continue reading

2009 update: RESERPINE is still best PROTECTION AGAINST SYMPATHETIC OVERLOAD.

This column last reported in January on reserpine’s central role in hypertension treatment. This review focuses on the crucial role of the most appropriate antihypertensive combination- lowdose reserpine + lowdose co-amilozide (amiloride + hydrochlorothiazide HCT) – against sudden death from … Continue reading

ADVERSE METABOLIC EFFECTS OF CHLORTHALIDONE, SPIRONOLACTONE AND ALL MODERN ANTIHYPERTENSIVES – BUT NOT LOWDOSE RESERPINE+CO-AMILORETIC.

A new paper from University Texas  states “chlorthalidone, the first-line drug therapy for hypertension”. They then show that it “causes persistent activation of sympathetic nervous system and insulin resistance in hypertensive patients. These side effects, however, are avoided by spironolactone … Continue reading

Getting to Goal Blood Pressure despite Disaster Capitalism: Why Reserpine Deserves a Second Look

 Lets hear your comments for or against  a return to evidence-based medicine for hypertension, not marketing  hype: Last week this op-ed column discussed the time-bomb of obesity–  overnutrition, and the wannabe panacea designer drugs of the Disease Industry. Instead of … Continue reading

2016 CHOOSING BREAST SCREENING, BAD DIET/LIFESTYLE ARE OBSESSIVE-COMPULSIVE DISORDERS. SCREENING MAMMOGRAPHY ASSAULT UPDATE : FLOOD OF PROGRESS AGAINST BREAST CANCER/ DISEASE.

neil.burman@gmail.com  Cape Town.                   read this  in concert with:               combating rising-occurrence-of-breast-cancer-in-younger-women;  and diet-nutritional– vitamin risks-and-benefits-for-breast-cancer.   UPDATE 22 APRIL 2016:     BREAST SCREENING OF WELL WOMEN … Continue reading

CAPE PENINSULA HYPERTENSION & HEADACHE CENTRE

CAPE PENINSULA HYPERTENSION & HEADACHE CENTRE (50 years of experience)      at       The Natural Medicine Clinic  NMC , 1st Floor, 15 Grove Bldg, Grove  Claremont, Cape Town- between  ABSA Parkade on Grove Ave, and Warwick Sq opp Cavendish. ph … Continue reading

update: COMPLEMENTARY, HOMEOPATHIC MEDICINE APPROVED IN SWITZERLAND, DEBATED IN AUSTRALIA, GERMANY AND SWEDEN

20 Oct 2014  an update Swedish perspective; Forsch Komplementmed. 2013;20(5):376-81. doi: 10.1159/000355916. Epub 2013 Oct 17.  Homeopathy: meta-analyses of pooled clinical data. Hahn RG.    Research Unit, Södertälje Hospital, Södertälje, Sweden. In the first decade of the evidence-based era, which began … Continue reading

COMBATTING THE INCREASING OCCURRENCE OF BREAST CANCER IN YOUNGER WOMEN.

UPDATE: 2 Mar  2014: PARACETAMOL ACETAMINOPHEN, DIGOXIN AND SPIRACTIN are ESTROGENIC: even the most popular and perhaps safest synthetic designer painkiller paracetamol acetaminophen (Tylenol, Panado) discovered in 1877   has again been shown  (Harvard University 2014- the Nurses’ Health Study from … Continue reading